MedPath
HSA Approval

FORTRANS FOR ORAL SOLUTION

SIN09234P

FORTRANS FOR ORAL SOLUTION

FORTRANS FOR ORAL SOLUTION

March 3, 1997

DKSH SINGAPORE PTE. LTD.

DKSH SINGAPORE PTE. LTD.

Regulatory Information

DKSH SINGAPORE PTE. LTD.

DKSH SINGAPORE PTE. LTD.

Therapeutic

General Sale List

Formulation Information

GRANULE, FOR SOLUTION

ORAL

Medical Information

A06AX

其它治疗便秘的药物

Manufacturer Information

DKSH SINGAPORE PTE. LTD.

BEAUFOUR IPSEN INDUSTRIE

Active Ingredients

MACROGOL 4000 (INN)

64 g

Polyethylene glycol

SODIUM CHLORIDE

1.46 g

Sodium chloride

POTASSIUM CHLORIDE

0.75 g

Potassium chloride

SODIUM SULPHATE ANHYDROUS

5.7 g

Sodium sulfate

SODIUM HYDROGEN CARBONATE

1.68 g

Sodium bicarbonate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FORTRANS FOR ORAL SOLUTION - HSA Approval | MedPath